A Rocky Road Ahead for FDA and Industry Politics and drug shortages will continue to impact FDA and drug manufacturers in 2023
BioPharm International
; 36(1):8-9, 2023.
Article
in English
| EMBASE | ID: covidwho-2320379
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Experimental Studies
Language:
English
Journal:
BioPharm International
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS